Liz Ticong

On The New York Times’ Hard Fork Live, OpenAI CEO Sam Altman called the company’s relationship with Microsoft “wonderfully good” despite reports of tension, while also pushing back on a lawsuit from the Times over user data. Joined by COO Brad Lightcap, Altman also addressed AI’s impact on the workforce and the need for more […]

New research shows Claude chats often lift users’ moods. Anthropic explores how emotionally supportive AI affects behavior, and where boundaries are needed.

Tesla’s robotaxi service just debuted in Austin, boosting the company’s stock by 8% as CEO Elon Musk declared the rollout a major success. But early videos from test rides revealed troubling on-road behavior. Shortly after the launch, footage emerged showing Tesla’s autonomous vehicles appearing to violate traffic laws, prompting scrutiny from federal regulators, according to […]

Elon Musk says he doesn’t use a computer. His posts — and gaming streams — say otherwise. What this legal claim means for AI’s future is no small thing.

In the Israel-Iran conflict, AI tools and deepfakes are being used by both sides to spread false visuals, distort reality, and manipulate public perception.

A yearlong study tracks daily US opinions on AI, revealing growing support across groups, even as concerns over job loss, misuse, and oversight persist.

Meta’s AI chatbot app is under fire after users discovered that their private prompts, including medical details, legal questions, and even personal confessions, are surfacing in a public “Discover” feed. Privacy experts call the leaks “incredibly concerning,” as many users appear unaware they’ve made sensitive prompts public. Reports from various sources confirm the feed shows […]

Waymo robotaxis were torched in LA protests over ICE raids, raising fears over AI surveillance and corporate tech in immigrant communities.

Mark Zuckerberg enters ‘founder mode’ to personally build Meta’s new Superintelligence Lab, aiming to leap ahead in the AGI race with a handpicked team.

A novel AI test created by UCL and the Institute of Cancer Research helps determine which men with high-risk, localized prostate cancer will respond positively to the hormone therapy drug abiraterone. Researchers say the test could maximize the possibility of cure and reduce NHS costs by ensuring treatment is only given when it is likely […]